Lexpos News

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Cefalexin 500mg capsules 21 £2.67 Chloramphenicol 0.5% eye drops 10 £2.90 Clarithromycin [...]

The post October 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

Achieving the thresholds for the monthly Pharmacy First payment has been an ongoing matter of great concern for pharmacy owners and Community Pharmacy England. Since the two previously agreed changes to the original thresholds, which were secured following our representations to the Department of Health and Social Care (DHSC) and NHS England, we have continued [...]

The post Pharmacy First: Further changes to monthly targets appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Chemydur® 60XL tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP073 Chemydur® 60XL tablets expires at 23.59pm on Friday 11 October 2024. After this date, any prescriptions for Chemydur® 60XL tablets must be [...]

The post Expiry of SSP073 Chemydur® 60XL tablets appeared first on Community Pharmacy England.

The Home Office has announced that the Ask for ANI emergency codeword scheme that was launched during the pandemic will conclude on 4th November 2024. Both the Ask for ANI and Safe Spaces programme featured in the 2022/23 Pharmacy Quality Scheme (PQS) with staff being asked to complete reading and training around the two schemes. [...]

The post PQS: Ask for ANI to wind down but Safe Spaces to continue appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd) Drug alert number: EL (24)A/48 Date issued: 10 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Linezolid 600 mg film-coated tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Linezolid 600 [...]

The post MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd) appeared first on Community Pharmacy England.